MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE >  Moneycontrol >  Markets > Announcements >  Pharmaceuticals > Announcement - Aurobindo Pharm
Aurobindo Pharm
BSE: 524804NSE: AUROPHARMAISIN: INE406A01037

23rd-Apr-2012 18:06Source: BSE

Aurobindo Pharm - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

M Sumanth Kumar Reddy has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

More Announcements on:

14th-Feb-2013 16:07Source: BSE

Aurobindo Pharm - Update -USFDA EIR for Unit VI of the Company

14th-Feb-2013 14:03Source: NSE

Aurobindo Pharma Limited

14th-Feb-2013 13:47Source: BSE

Aurobindo Pharm - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

14th-Feb-2013 13:31Source: BSE

Aurobindo Pharm - Aurobindo Pharma receives USFDA Finals Approvals for Pioglitazone Tablets and Pioglitazone Hydrochloride + Metformin Hydrochloride Tablets

14th-Feb-2013 11:42Source: NSE

Aurobindo Pharma Limited

11th-Feb-2013 12:58Source: NSE

Aurobindo Pharma Limited

11th-Feb-2013 11:49Source: BSE

Aurobindo Pharm - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

8th-Feb-2013 11:16Source: BSE

Aurobindo Pharm - Fixes Record Date for Interim Dividend

8th-Feb-2013 09:12Source: NSE

Aurobindo Pharma Limited

8th-Feb-2013 09:12Source: NSE

Aurobindo Pharma Limited

Board Meeting (Aurobindo Pharm)

Meeting Date

Remark

2013-05-30

Audited Results & Final Dividend

Add to Watchist
close[x]
Have you invested in these stocks? You can track them better in your Portfolio
Edit Watchlist
IPL 2013 spot-fixing controversy: Has the credibility of the IPL hit rock bottom?
Yes
No

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window